Data
The foundations, charities, and advocacy organizations advancing psychedelic research, education, access, and reform. Updated 2026-07.
While most investors focus on for-profit companies, nonprofits have driven much of the progress in psychedelics over the past several decades — the research, clinical trials, public education, harm reduction, and policy reform that built the field. This directory lists 36 active organizations across 8 countries.
36 organizations shown
A UK think tank and NGO founded in 1998 by Amanda Feilding that develops and funds psychedelic and cannabis research through international collaborations and advocates for evidence-based drug-policy reform.
A nonprofit that produces public education and cultural understanding about psychedelic plant medicines, bridging ceremonial use and psychedelic science while advancing psychedelic justice, reciprocity, and diversity.
A nonprofit providing harm-reduction education, drug-checking services, and health outreach in music and nightlife communities to promote safety among people who use psychedelics and other drugs.
A national grassroots organization founded in 2019 in Oakland that works to decriminalize and expand access to entheogenic plants and fungi through community organizing, education, and local policy campaigns.
A leading 501(c)(3) drug-policy reform nonprofit advocating that drug regulation be grounded in evidence, health, equity, and human rights, and working to end the war on drugs.
A 501(c)(3) educational nonprofit providing objective, non-judgmental information about psychoactive plants and chemicals, and archiving materials including the personal papers of Alexander and Ann Shulgin.
A nonprofit operating a free Psychedelic Peer Support Line offering confidential emotional support by phone and text to people during and after psychedelic experiences, plus a certified peer-coaching program.
A 501(c)(3) created to make MDMA-assisted therapy available to all veterans with PTSD through the VA, credited with securing the first Congressional appropriation for nationwide MDMA-AT trials; has merged with Heroic Hearts Project.
Incorporated in 1993, this 501(c)(3) scientific nonprofit helps design, review, and fund high-quality research on psilocybin and related psychedelics at leading universities in the US and Europe.
Founded in 2017 by former Army Ranger Jesse Gould, this nonprofit connects and funds military veterans with PTSD to access legal, evidence-based psychedelic therapy retreats and coaching; recently merged with Healing Breakthrough.
A nonprofit founded in 2009 with UN ECOSOC consultative status that addresses the social, legal, cultural, and health dimensions of ayahuasca, iboga, and other traditional plant medicines, including legal defense and harm reduction.
A registered Canadian charitable nonprofit (incorporated 2011) supporting psychedelic-assisted therapy research and education, including Canadian sites for MDMA-assisted therapy trials, funded entirely by public donation.
A nonprofit mental-health organization advancing legal, safe, evidence-based psychedelic therapy through research, education, and training, and a partner of the OVID Clinic Berlin.
A registered charity that expanded mental-health treatment options through psychedelic-assisted therapies; its advocacy helped Australia become the first nation to reschedule MDMA and psilocybin for clinical use in 2023, and it trains clinicians via its CPAT program.
A nonprofit founded by Dr. Martin Polanco that raises funds to provide ibogaine and 5-MeO-DMT psychedelic therapy for veterans and first responders with PTSD, depression, and service-related mental health conditions.
A nonprofit that funds psychedelic-assisted therapy (notably ibogaine) for veterans and first responders via scholarships, and supports federal legislation expanding access such as the Innovative Therapies Centers of Excellence Act.
Founded in 1986 by Rick Doblin, MAPS is a 501(c)(3) research and educational nonprofit working to create legal, evidence-based pathways to psychedelics, best known for pioneering MDMA-assisted therapy research for PTSD.
A nonprofit cultivating ethics and integrity in the emerging psychedelic industry, best known for developing the North Star Ethics Pledge with input from clinicians, elders, investors, and community stakeholders.
Founded in 2007, a leading European nonprofit advancing knowledge of psychedelics through research, education, and conferences, and host of ICPR, Europe's largest interdisciplinary psychedelic science conference.
A foundation promoting the use of psychedelics to treat addiction and PTSD, developing program models and education to help people struggling with substance use and trauma reconnect and heal.
A nonprofit providing financial scholarships to remove the cost barriers preventing people from accessing psychedelic healing, beginning with ketamine-assisted therapy.
A 501(c)(3) association of attorneys and policy experts across practice areas dedicated to solving the novel legal, ethical, and policy issues of the emerging psychedelics sector, co-founded in 2021.
A women-led 501(c)(3) advocacy nonprofit founded by Melissa Lavasani that advances federal and state policy for psychedelic medicine through briefings, campaigns, and policy analysis.
Founded in 2017, a community of roughly 180 philanthropists coordinating giving to advance safe, ethical, evidence-based psychedelic healing; has mobilized an estimated $50 million for research and advocacy.
Founded in 2014, a not-for-profit worker cooperative building a culture that respects the potential of psychedelics through education, events, breathwork, and community programming, with a large public following.
The first European Citizens' Initiative on psychedelics — a pan-European coalition of 32+ organizations across 18 countries campaigning to integrate psychedelic-assisted therapies into EU healthcare, research, and drug scheduling.
A family philanthropy founded in 2007 that has long funded psychedelic research and other early-stage mental-health causes, including major grants to MAPS.
An Oregon nonprofit that funds psilocybin therapy access for underserved communities, facilitator training, and research within Oregon's regulated psilocybin model.
A 501(c)(3) founded in 2017 that awards grants to students and community members conducting psychedelic research worldwide; the organization has announced an orderly wind-down to conclude by the end of 2026.
An international grassroots network (founded 1998) of 150+ student chapters advocating for sensible drug policy, decriminalization, harm reduction, and youth education; its foundation arm is a 501(c)(3).
A client-oriented scholarship-fund nonprofit that provides financial assistance to help people afford psychedelic therapy with vetted, licensed professionals, starting with ketamine-assisted therapy.
A grassroots nonprofit founded in 2019 advancing legal, compassionate access to psilocybin- and MDMA-assisted psychotherapy for Canadians in medical need, through clinician training, patient support, and Charter litigation.
A Colorado-based nonprofit conducting real-world, observational psychedelic research in partnership with institutions like Johns Hopkins, UCSF, and Imperial College London, and providing public education.
A 501(c)(3) nonprofit medical research organization developing psilocybin for major depressive disorder, known for open-science publishing and running large-scale psilocybin clinical trials.
A 501(c)(3) founded in 2019 by Marcus and Amber Capone that provides grants for veterans to access psychedelic-assisted therapies for PTSD and traumatic brain injury; has funded treatment for 1,000+ veterans.
A MAPS-affiliated psychedelic peer-support and harm-reduction project that trains volunteers and provides compassionate care for people having difficult psychedelic experiences at festivals and events; has trained over 6,000 volunteers.
Run a psychedelic nonprofit, or spot one we should add or update? Get in touch. This directory highlights active organizations and is not exhaustive; consider supporting the causes whose work you value.